StonvexLoading…
StonvexStonvexStonvexCore line items from CSGP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $897.00M | $3.25B | $2.35B | $1.51B |
Operating Income | $3.00M | $-72.00M | $-121.10M | $-70.00M |
Net Income | $3.00M | $7.00M | $-39.50M | $-8.60M |
EPS (Diluted) | $0.01 | $0.02 | $-0.09 | $-0.02 |
Total Assets | $10.16B | $10.54B | $10.82B | $10.51B |
Total Liabilities | $2.21B | $2.17B | $2.20B | $1.91B |
Cash & Equivalents | $1.22B | $1.63B | $1.94B | $3.63B |
Free Cash Flow OCF − CapEx | $107.00M | $123.00M | $21.70M | $27.20M |
Shares Outstanding | 414.00M | 417.90M | 416.70M | 415.10M |